MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.mtbio.2026.103348

Медицинская библиотека · Materials today. Bio · 2026

Advancing photocytotoxicity evaluation of nitric oxide derivative-ruthenium complex in 3D biofabricated breast cancer models.

Becceneri Amanda Blanque, Liu Suihong, Yildirim Sendegul, Kim Myoung Hwan, Liu Youdi, Namli Ilayda, Umstead Todd M, Chroneos Zissis C, da Silva Roberto Santana, Ozbolat Ibrahim T

СтатьяПеревод пока не подготовлен

Аннотация

Cancer remains a major health challenge, emphasizing the need for innovative therapies. Photodynamic therapy (PDT) uses light-activated photosensitizers (PSs) to induce targeted cancer cell death, but clinical translation is limited by low tumor specificity, toxicity, and inadequate in vitro models. Three-dimensional (3D) tumor models provide physiologically relevant platforms that enhance translational predictability. Here, we evaluated a promising photoactivated ruthenium-based PS, {TPyP [Ru(NO2) (bpy)2]4}(PF6)4 complex (RuNO2TPyP), across 3D cancer models of increasing complexity, including free-standing spheroids, bioprinted spheroids within hydrogel matrix, and bioprinted patient-derived organoids (PDOs). The RuNO2TPyP complex triggered significant cell death and apoptosis while reducing tumor aggressiveness following PDT. Its efficacy was model-dependent: effective at 0.19 μM in free-standing spheroids, requiring higher concentrations (0.78 μM) in bioprinted spheroids embedded within a hydrogel matrix that mimics the tumor extracellular microenvironment, and showing substantial resistance in bioprinted PDOs (1.56 μM). These findings underscore the significance of bioprinted 3D models and establish a basis for future investigations of this and related PSs in personalized cancer therapy.

Для цитирования: Becceneri Amanda Blanque, Liu Suihong, Yildirim Sendegul, Kim Myoung Hwan, Liu Youdi, Namli Ilayda, Umstead Todd M, Chroneos Zissis C, da Silva Roberto Santana, Ozbolat Ibrahim T. Advancing photocytotoxicity evaluation of nitric oxide derivative-ruthenium complex in 3D biofabricated breast cancer models.. Materials today. Bio. 2026. DOI: 10.1016/j.mtbio.2026.103348.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.